Home » Topics » Respiratory, BioWorld Science

Respiratory, BioWorld Science
RSS

Labopharm and Sepracor to develop solid oral form of levalbuterol

Jan. 23, 1997

New antiasthma agents from Tanabe Seiyaku

Jan. 23, 1997

SmithKline Beecham reports new antiinflammatory/antiallergic agents

Jan. 23, 1997

TBC cell adhesion inhibitor enters clinic

Jan. 22, 1997

Celltech reports new PDE IV inhibitors

Jan. 21, 1997

cAMP PDE inhibitors disclosed by Nippon Kayaku

Jan. 20, 1997

Therapeutically active glycomimetic saccharopeptides from Glycomed

Jan. 17, 1997

Schering-Plough develops dual PAF and histamine antagonist

Jan. 16, 1997

New antihistamines in the pipeline at HMR

Jan. 16, 1997

Inhale/Centeon agreement for alpha1-proteinase inhibitor

Jan. 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...